Article
New Patent-Defense Path for Pharma
Article
New Patent-Defense Path for Pharma
October 2014
Just over three years ago, Congress enacted the America Invents Act, hailed as "one of the most significant legislative reforms to the patent system in our Nation's history." The Act included several sweeping changes, including advent of Inter Partes Review (IPR)—a new litigation procedure held before the Patent Trial and Appeal Board (PTAB) to challenge the validity of patent claims. Designed to be a faster and less expensive alternative to district court litigation, IPRs have taken the patent bar by storm.